Germany - Events
Welcome to the Pharma Partnering EU Summit 2025! Join us in Munich for a one-of-a-kind event where pharma professionals come together to network, learn, and collaborate. This in-person summit is your chance to connect with industry leaders, discover the latest trends, and explore partnership opportunities. Don't miss out on this exciting opportunity to expand your network and stay ahead in the ever-evolving pharma landscape. Secure your spot today!
Registration Link: https://pharma-partnering-summit.com/registration.html
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape-such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I-2024 was a pivotal year for the industry to accelerate innovation.
Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry!
Get stuck into topics such as:
- Explore novel clinical and preclinical candidate data to produce best-in-class drugs for diverse indications- Understand contemporary indication expansion strategies to maximise the value of your pipeline and diversify your immuno-inflammatory portfolio- Colla…
The Life Sciences Strategy Summit on IP and Exclusivity is a premier annual event convening pharmaceutical, biotech, and legal professionals to explore the evolving landscape of intellectual property and regulatory exclusivity. Scheduled for October 2025 in Munich, Germany, the summit offers a platform for in-depth discussions on patent strategies, regulatory frameworks, and market exclusivity challenges.
Attendees can anticipate sessions on the latest developments in Supplementary Protection Certificates (SPCs), including the implications of recent CJEU decisions and the SPC waiver's impact on both generic and innovator strategies. The conference will also delve into the intersection of regulatory and IP law, with topics covering clinical trials, data exclusivity, and the Pharmaceutical…
